Jonathan Yong

Stock Analyst at UBS

(3.80)
# 1,968
Out of 5,090 analysts
82
Total ratings
56.4%
Success rate
12.7%
Average return

Stocks Rated by Jonathan Yong

Alignment Healthcare
Oct 30, 2026
Reiterated: Hold
Price Target: $9 → $8
Current: $7.27
Upside: +10.04%
Oscar Health
Oct 12, 2026
Rated: Hold
Price Target: $26 → $36
Current: $30.37
Upside: +18.54%
Clover Health Investments
Aug 6, 2026
Reiterated: Hold
Price Target: $4.75 → $5
Current: $4.46
Upside: +12.11%
eHealth
Aug 5, 2026
Reiterated: Hold
Price Target: $2 → $1.75
Current: $0.4921
Upside: +255.62%
Definitive Healthcare
Aug 15, 2023
Reiterated: Hold
Price Target: $12 → $11
Current: $1.12
Upside: n/a
GoodRx Holdings
Aug 9, 2023
Reiterated: Hold
Price Target: $8
Current: $3.49
Upside: n/a
Labcorp Holdings
Jun 5, 2023
Reiterated: Buy
Price Target: $288
Current: $361.39
Upside: n/a
McKesson
May 12, 2023
Reiterated: Buy
Price Target: $450
Current: $994.58
Upside: n/a
AMN Healthcare Services
May 5, 2023
Reiterated: Buy
Price Target: $128 → $115
Current: $47.11
Upside: n/a
American Well
May 4, 2023
Reiterated: Hold
Price Target: $3.5
Current: $12.73
Upside: n/a
Reiterated: Buy
Price Target: $199
Current: $330.84
Upside: n/a
Reiterated: Hold
Price Target: $7.4
Current: $2.40
Upside: n/a
Reiterated: Buy
Price Target: $76
Current: $135.90
Upside: n/a
Reiterated: Buy
Price Target: $95
Current: $29.96
Upside: n/a
Reiterated: Hold
Price Target: $17
Current: $24.52
Upside: n/a
Reiterated: Buy
Price Target: $350
Current: $204.78
Upside: n/a
Reiterated: Hold
Price Target: $27
Current: $8.51
Upside: n/a
Reiterated: Buy
Price Target: $157 → $163
Current: $176.05
Upside: n/a
Reiterated: Hold
Price Target: $17
Current: $0.2542
Upside: n/a
Reiterated: Buy
Price Target: $41
Current: $21.48
Upside: n/a
Reiterated: Buy
Price Target: $8
Current: $27.68
Upside: n/a
Reiterated: Buy
Price Target: $97
Current: $84.88
Upside: n/a
Reiterated: Buy
Price Target: $27 → $23
Current: $29.82
Upside: n/a
Reiterated: Hold
Price Target: $4 → $3
Current: $0.357
Upside: n/a
Reiterated: Hold
Price Target: $92
Current: $250.48
Upside: n/a
Reiterated: Buy
Price Target: $106
Current: $68.45
Upside: n/a
Reiterated: Buy
Price Target: $635
Current: $414.50
Upside: n/a